Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where A. Morrison is active.

Publication


Featured researches published by A. Morrison.


Transfusion | 2009

Pathogen reduction of fresh plasma using riboflavin and ultraviolet light: effects on plasma coagulation proteins.

V. Hornsey; Olive Drummond; A. Morrison; L. McMillan; Ian MacGregor; Chris Prowse

BACKGROUND: Treatment with riboflavin and ultraviolet (UV) light reduces the pathogens present in blood components. This study assessed changes to the coagulation proteins that had occurred during this treatment of fresh plasma units before freezing.


Vox Sanguinis | 2008

Cold storage of pooled, buffy‐coat‐derived, leucoreduced platelets in plasma

V. Hornsey; Olive Drummond; L. McMillan; A. Morrison; L. Morrison; Ian MacGregor; C. Prowse

Background  This study was designed to determine which in vitro assays would be most useful for studying the effects of cold storage on platelet concentrates and to establish an in vivo model for platelet recovery and survival.


Vox Sanguinis | 2007

Use of the DiaMed Impact R to test platelet function in stored platelet concentrates

A. Morrison; V. Hornsey; C. Prowse; Ian MacGregor

Background and Objectives The DiaMed Impact R tests platelet function under close to physiological flow conditions using cone and plate technology. An image analyser quantifies the adhered platelets and results are expressed as percentage of well surface covered by aggregates (SC %) as an index of adhesion and average size of the aggregates (AS µm2) as an index of aggregation. The machine is designed to use whole blood and the aim of this study was to determine if it could be used to assess platelet function in platelet concentrates (PC).


Biomaterials | 2011

Polymers for the rapid and effective activation and aggregation of platelets

Anne Hansen; L. McMillan; A. Morrison; Juraj Petrik; Mark Bradley

Platelets are responsible for plugging sites of vascular injury, where upon activation they spread out and become cross-linked, preventing further blood loss. It is desirable to control the activation process on demand for applications such as the rapid staunching of blood flow following trauma. Polymers are the material of choice in many biological areas, with physical properties that allow control of morphology as well as ease of functionalisation and production. Herein, polymer microarrays were used to screen a complex human fluid (platelet rich plasma) to identify polyacrylates that could be used to modulate platelet activation. Several polymers were identified which rapidly activated platelets as determined by CD61P binding and subsequent confirmation by scanning electron microcopy analysis. This approach enabled a direct comparison between the natural agonist collagen and synthetic polymers with respect to the activation status of the platelets as well as the number of bound platelets. Further investigations under physiological flow demonstrated that the static microarray experiments gave viable candidates for potential medical applications while specific protein binding to the polymers was identified as a possible mode of action. The approach demonstrates the ability of polymer microarrays to identify new polymers for specific biological activation events and in this case allowed the identification of materials that allowed higher levels of platelets to bind in advanced activation states than the natural standard collagen in static and flow studies.


Transfusion | 2008

Freezing of buffy coat–derived, leukoreduced platelet concentrates in 6 percent dimethyl sulfoxide

V. Hornsey; L. McMillan; A. Morrison; Olive Drummond; Ian MacGregor; Chris Prowse

BACKGROUND: There has recently been renewed interest in freezing platelets (PLTs) in dimethyl sulfoxide (DMSO) for the treatment of major traumatic injuries, especially in military situations. This study examined PLTs that were frozen in small volumes of 6 percent DMSO at −80°C.


Vox Sanguinis | 2014

Storage of apheresis platelet concentrates after manual replacement of >95% of plasma with PAS 5

A. Morrison; L. McMillan; K. Radwanski; O. Blatchford; K. Min; Juraj Petrik

Recently, a glucose‐ and bicarbonate‐containing additive solution termed PAS 5 demonstrated acceptable 7‐day platelet storage after >95% plasma replacement with PAS on the day of collection (Day 0). In this study, we examined platelet storage in >95% PAS 5 after manual washing of Day 1 apheresis platelets in plasma collected using either the Amicus or Trima plateletpheresis devices.


Transfusion Medicine | 2015

Evaluation of a potassium removal filter on irradiated red cells stored in SAGM

A. Morrison; L. McMillan; J. D. M. Campbell; Juraj Petrik

Irradiation of red cell concentrates RCCs) can lead to well‐documented elevated extracellular potassium concentrations. Transfusion of these products has the potential, if given as a massive/rapid transfusion, to lead to transient hyperkalemia. A potassium absorption filter (PAF) has recently been developed and has been proven to effectively remove excess K+. However, data are lacking on the red cell quality parameters over storage after irradiation.


Vox Sanguinis | 2011

Characteristics of prion‐filtered red cells suspended in pathogen‐inactivated plasma (MB treated or solvent‐detergent treated) for neonatal exchange transfusion

V. Hornsey; C. Casey; K. McColl; H. Young; Olive Drummond; L. McMillan; A. Morrison; C. Prowse

Background and Objectives  Neonates undergoing exchange transfusion require < 5‐day‐old red cells suspended in plasma. This study assesses the effect of replacing the saline, adenine, glucose and mannitol (SAGM) of prion reduced (P‐Capt) red cells with either methylene blue–treated plasma (MBTFFP) or OctaplasLG to reduce the risk of variant Creutzfelt–Jakob disease transmission.


Vox Sanguinis | 2010

A Novel B-Weak Hybrid Allele With A Non-Repeating Cbf-Enhancer Region

A. Morrison; L. McMillan; V. Hornsey; C. Prowse

Background and Objectives  The DiaMed Impact R tests platelet function under close to physiological flow conditions. The machine is designed to use whole blood but by adding back compatible red cells, it can be used to study stored platelet concentrates. To date, red cells ≤14 days old have been used. In this study, the effect on the assay of using red cells stored for up to 60 days was examined.


Transfusion | 2018

Timing of gamma irradiation and blood donor sex influences in vitro characteristics of red blood cells: TIMING AND DONOR SEX AFFECT GAMMA-IRRADIATED RBCs

Dirk de Korte; Louis Thibault; Wiebke Handke; Sarah K. Harm; A. Morrison; Aine Fitzpatrick; Denese C. Marks; Qi-Long Yi; Jason P. Acker

There are few studies investigating the effect of irradiation on red blood cells (RBCs) during storage. This study analyzed changes in in vitro quality of RBCs irradiated at several points during storage with the aim of providing evidence to support current maximum pre‐ and postirradiation storage limits.

Collaboration


Dive into the A. Morrison's collaboration.

Top Co-Authors

Avatar

L. McMillan

Scottish National Blood Transfusion Service

View shared research outputs
Top Co-Authors

Avatar

Ian MacGregor

Scottish National Blood Transfusion Service

View shared research outputs
Top Co-Authors

Avatar

V. Hornsey

Scottish National Blood Transfusion Service

View shared research outputs
Top Co-Authors

Avatar

C. Prowse

Scottish National Blood Transfusion Service

View shared research outputs
Top Co-Authors

Avatar

Olive Drummond

Scottish National Blood Transfusion Service

View shared research outputs
Top Co-Authors

Avatar

Juraj Petrik

Scottish National Blood Transfusion Service

View shared research outputs
Top Co-Authors

Avatar

Chris Prowse

Scottish National Blood Transfusion Service

View shared research outputs
Top Co-Authors

Avatar

Anne Hansen

University of Edinburgh

View shared research outputs
Top Co-Authors

Avatar

J. D. M. Campbell

Scottish National Blood Transfusion Service

View shared research outputs
Top Co-Authors

Avatar

K. McColl

Scottish National Blood Transfusion Service

View shared research outputs
Researchain Logo
Decentralizing Knowledge